Article
Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling.
Nature immunology - 1 Feb 2006
Collins Brian E, Smith Brian A, Bengtson Per, Paulson James C
Abstract excerpt
CD22 is a negative regulator of B cell signaling, an activity modulated by its interaction with glycan ligands containing alpha2-6-linked sialic acids. B cells deficient in the enzyme (ST6Gal I) that forms the CD22 ligand show suppressed BCR signaling. Here we report that mice deficient in both CD22 and its ligand (Cd22-/- St6gal1-/- mice) showed restored B cell receptor (BCR) signaling, suggesting that the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
